| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/30/2009 | US20090111357 Cosmetic appliance and method of use |
| 04/30/2009 | US20090110744 Sustained release pharmaceutical compositions |
| 04/30/2009 | US20090110743 Porous beta-tricalcium phosphate granules and methods for producing same |
| 04/30/2009 | US20090110742 Long-acting colloidal insulin formulation and its preparation |
| 04/30/2009 | US20090110741 Method and compositions for polymer nanocarriers containing therapeutic molecules |
| 04/30/2009 | US20090110740 Materials and Methods for Modulating Metabolism |
| 04/30/2009 | US20090110739 Targeted cancer chemotherapy using synthetic nanoparticles |
| 04/30/2009 | US20090110738 Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110737 Orally Disintegrating Powder Comprising Cilostazol and Mannitol |
| 04/30/2009 | US20090110736 Alloplastic injectable dermal filler and methods of use thereof |
| 04/30/2009 | US20090110735 Controlled release formulations |
| 04/30/2009 | US20090110734 Quaternised ammonium cyclodextrin compounds |
| 04/30/2009 | US20090110733 Delivery means |
| 04/30/2009 | US20090110732 Bioresorbable composition for repairing skeletal tissue |
| 04/30/2009 | US20090110731 Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110730 Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110729 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them |
| 04/30/2009 | US20090110728 Zero-Order Modified Release Solid Dosage Forms |
| 04/30/2009 | US20090110727 Extended release compositions of proton pump inhibitors |
| 04/30/2009 | US20090110726 Formulation having accurate dose-dividing function |
| 04/30/2009 | US20090110725 Solid, orodispersible and/or dispersible composition, without an excipient of known effect and its process of preparation |
| 04/30/2009 | US20090110724 Compositions and methods for treatment of pain |
| 04/30/2009 | US20090110723 Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms |
| 04/30/2009 | US20090110722 Composition |
| 04/30/2009 | US20090110721 Paneled capsule shells for release of pharmaceutical compositions |
| 04/30/2009 | US20090110720 Use of compounds for the prevention of drug-induced cell toxicity |
| 04/30/2009 | US20090110719 Polyamine modified particles |
| 04/30/2009 | US20090110718 Derivatives of tiacumicin B as anti-cancer agents |
| 04/30/2009 | US20090110717 Transmucosal composition |
| 04/30/2009 | US20090110716 Orally disintegrative dosage form |
| 04/30/2009 | US20090110715 Edible film Package Having Product for Oral Intake Enclosed Therein |
| 04/30/2009 | US20090110709 Composition comprising an effective amount of a polyphenolic compound, in particular, ellagic acid and/or tannic acid, and a peptide for protection against degradation of cutaneous elastic fibers by elastolytic enzymes; for treating aging or damaged skin |
| 04/30/2009 | US20090110704 Cosmetic composition based on a magnetic or magnetisable material, the preparation thereof and use thereof for cleansing the epidermis |
| 04/30/2009 | US20090110647 Method of preventing adverse effects by glp-1 |
| 04/30/2009 | US20090110646 Product for Treating the Skin and Mucous Membranes, and Relative Method of Preparation |
| 04/30/2009 | US20090110645 Use of metal astringents for the treatment and prevention of hairy heel warts |
| 04/30/2009 | US20090110644 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 04/30/2009 | US20090110643 Method of Producing Liposomes Containing Gas Enclosed Therein |
| 04/30/2009 | US20090107495 Device for inhalation of medicine |
| 04/30/2009 | DE102007051614A1 Retinolhaltiges Kosmetikprodukt Retinolhaltiges cosmetic product |
| 04/30/2009 | DE102007051059A1 Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen Biomaterial for the controlled release of active ingredients |
| 04/30/2009 | DE102007048217A1 Verfahren zur Herstellung langzeitstabiler amorpher Arzneimittel A process for producing long-term stability of amorphous drug |
| 04/30/2009 | CA2740960A1 Immuno-modulatory composition |
| 04/30/2009 | CA2703652A1 A standardized plant extract, process for obtaining the same and uses thereof |
| 04/30/2009 | CA2703365A1 Nifedipine-containing press coated tablet and method of preparing the same |
| 04/30/2009 | CA2703338A1 Method of preventing adverse effects by glp-1 |
| 04/30/2009 | CA2703313A1 Oral dosage forms comprising licarbazepine acetate |
| 04/30/2009 | CA2703234A1 Delivery of active agents |
| 04/30/2009 | CA2703224A1 Pharmaceutical formulation of clavulanic acid |
| 04/30/2009 | CA2703179A1 Liposomal vancomycin formulations |
| 04/30/2009 | CA2703152A1 Lipoic acid pellet composition |
| 04/30/2009 | CA2703004A1 Apparatus and method for continuous production of spherical powder pellets |
| 04/30/2009 | CA2702919A1 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 04/30/2009 | CA2702800A1 Long acting injectable formulations |
| 04/30/2009 | CA2702506A1 Anti-malarial pharmaceutical composition |
| 04/30/2009 | CA2698327A1 Pharmaceutical product comprising yeast |
| 04/29/2009 | EP2052753A1 Method and apparatus for vaporizing a compound |
| 04/29/2009 | EP2052736A1 Parathyroid hormone formulations und uses thereof |
| 04/29/2009 | EP2052723A1 Stable lyophilized preparation |
| 04/29/2009 | EP2052718A1 Patch preparation |
| 04/29/2009 | EP2052717A1 Multiparticulate O-desmethylvenlafaxine salts and uses thereof |
| 04/29/2009 | EP2052716A1 Controlled release formulations |
| 04/29/2009 | EP2052714A1 Topical gel delivery systems for treating skin disorders |
| 04/29/2009 | EP2052710A2 Seamless capsule manufacturing method |
| 04/29/2009 | EP2052697A1 Metering and packaging of controlled release medication |
| 04/29/2009 | EP2052696A1 System for evaluating mastication function and artificial food mass |
| 04/29/2009 | EP2051757A1 Drug capsules for dry powder inhalers |
| 04/29/2009 | EP2051737A2 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 04/29/2009 | EP2051704A1 Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water |
| 04/29/2009 | EP2051702A1 Multi-phasic pharmaceutical formulations of poorly water-soluble drugs for reduced fed/fasted variability and improved oral bioavailability |
| 04/29/2009 | EP2051701A2 Compositions comprising calcium citrate malate and methods for making the same |
| 04/29/2009 | EP2051700A2 Compositions comprising calcium citrate malate and methods for making the same |
| 04/29/2009 | EP2051699A2 Photosensitizer formulations for topical applications |
| 04/29/2009 | EP2051698A1 A liposomal complex of sodium carboxymethyl beta-glucan |
| 04/29/2009 | EP2051697A2 Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof |
| 04/29/2009 | EP2051696A2 Stable liquid levetiracetam compositions and methods |
| 04/29/2009 | EP2051695A2 Implantable sustained drug delivery device for releasing active agents to the ostiomeatal complex |
| 04/29/2009 | EP2051694A2 Pharmaceutical compositions comprising aripiprazole |
| 04/29/2009 | EP2051693A1 Pharmaceutical compositions easy to swallow, not causing any unpleasant oral sensation and comprising particles with an active principle |
| 04/29/2009 | EP2051692A1 Emulsion concentrate |
| 04/29/2009 | EP2051659A2 Method for the production of a porous, ceramic surface layer |
| 04/29/2009 | EP1845996A4 Compositions and methods relating to novel compounds and targets thereof |
| 04/29/2009 | EP1794590A4 Enhanced stability of proteins immobilized on nanoparticles |
| 04/29/2009 | EP1784177B1 Formulation for l-tryptophane comprising carbidopa/benserazide |
| 04/29/2009 | EP1620065A4 Oral care tablet |
| 04/29/2009 | EP1558269B1 Botulinum toxin formulations for oral administration |
| 04/29/2009 | EP1552822B1 Patch |
| 04/29/2009 | EP1509207B1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 04/29/2009 | EP1509206B1 A hemostatic composition |
| 04/29/2009 | EP1485072B1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion. |
| 04/29/2009 | EP1465608B1 Extended release compositions comprising as active compound venlafaxine hydrochloride |
| 04/29/2009 | EP1399133B1 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 04/29/2009 | EP1343475B1 Self forming, thermodynamically stable liposomes |
| 04/29/2009 | EP1313482B1 Pharmaceutical composition and method for treating hypogonadism |
| 04/29/2009 | EP1304992B1 Topical gel delivery systems for treating skin disorders |
| 04/29/2009 | EP1296652B1 Topical pharmaceutical formulations and methods of treatment |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1119345B1 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 04/29/2009 | EP1047433A4 Cellulose derivatives and colorectal cancer risk reduction |
| 04/29/2009 | CN101420991A Polymer compositions and methods for their use |